Mani Foroohar

Stock Analyst at Leerink Partners

(1.49)
# 2,413
Out of 4,438 analysts
147
Total ratings
42.55%
Success rate
-14.7%
Average return
Main Sectors:
Top Industries:

26 Stocks

Neurogene
Apr 29, 2024
Initiates: Outperform
Price Target: $46
Current: $32.52
Upside: +41.45%
CureVac
Apr 25, 2024
Downgrades: Market Perform
Price Target: $12$4
Current: $3.29
Upside: +21.58%
Mirum Pharmaceuticals
Mar 18, 2024
Maintains: Outperform
Price Target: $44$43
Current: $25.79
Upside: +66.73%
REGENXBIO
Mar 6, 2024
Upgrades: Outperform
Price Target: n/a
Current: $15.33
Upside: -
enGene Holdings
Feb 20, 2024
Initiates: Outperform
Price Target: $31
Current: $13.27
Upside: +133.61%
AlloVir
Dec 22, 2023
Downgrades: Market Perform
Price Target: $1
Current: $0.80
Upside: +25.66%
Wave Life Sciences
Dec 19, 2023
Upgrades: Outperform
Price Target: $12
Current: $6.32
Upside: +89.87%
Tenaya Therapeutics
Nov 30, 2023
Initiates: Outperform
Price Target: $7
Current: $4.18
Upside: +67.46%
Lexeo Therapeutics
Nov 28, 2023
Initiates: Outperform
Price Target: $19
Current: $15.00
Upside: +26.67%
Arrowhead Pharmaceuticals
May 12, 2023
Downgrades: Market Perform
Price Target: $40
Current: $25.02
Upside: +59.87%
BridgeBio Pharma
Apr 13, 2023
Maintains: Outperform
Price Target: $25$27
Current: $29.28
Upside: -7.79%
4D Molecular Therapeutics
Apr 13, 2023
Maintains: Market Perform
Price Target: $14$13
Current: $25.15
Upside: -48.31%
Moderna
Feb 24, 2023
Downgrades: Underperform
Price Target: $111$93
Current: $143.69
Upside: -35.28%
Ionis Pharmaceuticals
Feb 23, 2023
Maintains: Market Perform
Price Target: $34$27
Current: $37.37
Upside: -27.75%
Recursion Pharmaceuticals
Jan 23, 2023
Maintains: Market Perform
Price Target: $9$8
Current: $9.51
Upside: -15.88%
Rocket Pharmaceuticals
Jan 23, 2023
Maintains: Outperform
Price Target: $50$49
Current: $22.33
Upside: +119.44%
Intellia Therapeutics
Jan 23, 2023
Maintains: Outperform
Price Target: $86$84
Current: $25.71
Upside: +226.72%
Editas Medicine
Jan 23, 2023
Maintains: Market Perform
Price Target: $6$7
Current: $5.51
Upside: +27.04%
bluebird bio
Jan 23, 2023
Maintains: Market Perform
Price Target: $9$8
Current: $1.00
Upside: +702.65%
Beam Therapeutics
Jan 23, 2023
Maintains: Outperform
Price Target: $81$77
Current: $24.80
Upside: +210.48%
Alnylam Pharmaceuticals
Jan 23, 2023
Maintains: Market Perform
Price Target: $144$143
Current: $149.62
Upside: -4.42%
Abeona Therapeutics
Nov 14, 2022
Maintains: Market Perform
Price Target: $5$6
Current: $4.31
Upside: +39.21%
CRISPR Therapeutics AG
Nov 7, 2022
Maintains: Outperform
Price Target: $75$76
Current: $54.76
Upside: +38.79%
Caribou Biosciences
May 12, 2022
Maintains: Outperform
Price Target: $30$34
Current: $3.09
Upside: +1,000.32%
Adverum Biotechnologies
Jul 23, 2021
Maintains: Market Perform
Price Target: $50$20
Current: $7.86
Upside: +154.45%
AVROBIO
May 3, 2021
Maintains: Market Perform
Price Target: n/a
Current: $1.38
Upside: -